Posts In: Gubba Pharma In E News

Molbio with Global Fund, USAID and Stop TB Partnership to expand access to rapid molecular tests

Global Fund, USAID and Stop TB Partnership entered into a collaboration with Goa-based Molbio Diagnostics, India’s leading point-of-care molecular diagnostics company and inventor of the...

Continue Reading

Aurobindo Pharma Foundation Funds Rs. 3 Cr for Vedasadanam Block at Sri Sankara Gurukula Veda Patasala

Aurobindo Pharma Foundation (APF), the philanthropic arm of Aurobindo Pharma Ltd, has inaugurated and dedicated Vedasadanam Block to Sankara Gurukula Veda Patasala located in Shameerpet,...

Continue Reading

Lupin receives USFDA’s nod for Brexpiprazole tablets

Drug firm Lupin said it has received approval from the US health regulator for Brexpiprazole tablets used to treat certain mental and mood disorders.The approval...

Continue Reading

Cipla to sell stake in Uganda arm for $25-30 million

Cipla Ltd, and its wholly owned subsidiaries, Cipla (EU) Limited, and Meditab Holdings Limited, have signed a Share Purchase Agreement with Africa Capitalworks SSA 3...

Continue Reading

Aurobindo Pharma arm gets U.S. FDA nod for cancer drug copy

Drugmaker Aurobindo Pharma’s subsidiary Eugia Pharma Specialities has received final approval from the U.S. Food and Drug Administration (U.S. FDA) to manufacture and market cancer...

Continue Reading

IIT Kanpur signs MoU with Reliance Life Sciences, hopes to ‘revolutionise’ gene therapy

In a first, the Indian Institute of Technology (IIT), Kanpur, has signed a memorandum of understanding (MoU) with Reliance Life Sciences Pvt. Ltd. to license...

Continue Reading

Lupin gets CDSCO panel nod to study Ranibizumab

The drug major Lupin has got the green signal from the Subject Expert Committee (SEC) from the Central Drug Standard Control Organisation (CDSCO) to study...

Continue Reading

Torrent Pharma enters into consumer market to address calcium deficiency in India

Torrent Pharmaceuticals Ltd announced that it has recently unveiled its first-ever 12-week-long campaign across TV and digital. With this new campaign, the pharma giant announces...

Continue Reading

Sun Pharma completes acquisition of Concert Pharmaceuticals

Dermatology drugThe drug major has successfully completed the acquisition of Concert Pharmaceuticals, Inc, a late-stage clinical biopharmaceutical company that is developing deuruxolitinib for the potential...

Continue Reading